This Fund Manager Rating is based on the Citywire Long Only ratings methodology
Citywire Ratings are rewarded for risk adjusted outperformance of benchmarks we select independently More information on how Ratings are calculated
About Marcel Fritsch
Marcel Fritsch is a global analyst for medical technology & healthcare services and a senior portfolio manager at Bellevue Asset Management. He is a member of Bellevue’s Healthcare Funds & Mandates team and manages the BB Adamant Medtech & Services (Lux) fund and the BB Adamant Global Medtech & Services (CH) fund. Prior to joining Bellevue in 2008, he was a management consultant with Deloitte Touche Tohmatsu, where he advised multinational companies in the medical technology, pharmaceutical and manufacturing sectors on strategic and operational issues. Fritsch graduated from the University of St. Gallen (HSG), where he earned an MSc in economics.
Citywire Rating: AAA rated
|View full league table|
Month by Month Performance